VICTORIA HARGRAVE: Open Payments
NPI 1023259967 · JERSEYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 94 payments from 19 companies in 2025. Trend: 2023 $1,938 · 2024 $1,502 · 2025 $1,439
Food & beverage: $1,439
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $331 |
| Janssen Pharmaceuticals, Inc | 12 | $202 |
| Axsome Therapeutics, Inc. | 10 | $136 |
| Lundbeck LLC | 6 | $113 |
| Amgen Inc. | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Novo Nordisk Inc | 4 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
Products named: VRAYLAR, REXULTI, SPRAVATO, Auvelity, QULIPTA, CAPLYTA, FANAPT, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
